NOT-HG-22-003: Notice of Early Termination of RFA-HG-21-033, Genome Research Experiences to Attract Talented Undergraduates into the Genomics Field to Enhance Diversity (R25 Clinical Trial Not Allowed)

Notice of Early Termination of RFA-HG-21-033, Genome Research Experiences to Attract Talented Undergraduates into the Genomics Field to Enhance Diversity (R25 Clinical Trial Not Allowed)

Notice Number:

NOT-HG-22-003

Key Dates

Release Date:

January 11, 2022

Related Announcements

NOT-HG-24-007 - Notice of NHGRI Participation in PAR-23-309, Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)

RFA-HG-21-033 - Genome Research Experiences to Attract Talented Undergraduates into the Genomics Field to Enhance Diversity (R25 Clinical Trial Not Allowed)

Issued by

National Human Genome Research Institute (NHGRI)

Purpose

Effective immediately, the Funding Opportunity Announcement (FOA) RFA-HG-21-033, "Genome Research Experiences to Attract Talented Undergraduates into the Genomics Field to Enhance Diversity (R25 Clinical Trial Not Allowed)" has been terminated.

Inquiries

Please direct all inquiries to:

Tina Gatlin, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 301-480-2280
Email: gatlincl@nih.gov